PSA 856 ng/mL时18F-DCFPyL PET/CT仅见单发大转移灶
本文报道一例前列腺癌生化复发患者,PSA高达856 ng/mL,但18F-DCFPyL PSMA PET/CT仅显示1个转移灶。联合雄激素剥夺治疗与放疗后获得完全生化缓解,提示高PSA水平与PSMA PET/CT转移灶数目之间关系可能并不一致。
要点
- 高PSA(856 ng/mL)时PSMA PET/CT也可能仅见单发转移灶。
- PSMA PET/CT可在低PSA水平检出寡转移并指导转移灶定向治疗。
- 本例联合ADT与放疗后获得完全生化缓解。
核心结论
- 高PSA水平并不必然对应PSMA PET/CT上多发转移,本病例PSA 856 ng/mL时仅见1个转移灶。
研究设计与样本
- 本文为单例病例报告,报道1例生化复发时PSA 856 ng/mL的前列腺癌患者的PSMA PET/CT表现及治疗反应。
主要发现
- 该患者生化复发时PSA为856 ng/mL,18F-DCFPyL PSMA PET/CT仅显示1个转移灶。
- 联合雄激素剥夺治疗与放疗后,患者获得完全生化缓解。
临床怎么用
- 对高PSA的前列腺癌生化复发患者,PSMA PET/CT仍可能显示寡转移,可据此考虑转移灶定向治疗。
局限性
- 本文为单例病例报告,不能据此推断PSA水平与PSMA PET/CT转移灶数目之间的普遍关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Literature shows that prostate-specific membrane antigen (PSMA) PET/CT may detect biochemical recurrence of prostate cancer at low prostate-specific antigen (PSA) levels, including detection of oligometastatic disease and hence direct metastasis-directed therapy. Although it is generally accepted that higher PSA values indicate higher disease burden, few data are available on the relation between PSA levels and number of detected metastases on PSMA PET/CT. This report demonstrates a patient with high PSA levels (856 ng/mL) at time of biochemical recurrence that showed only 1 metastasis on PSMA PET/CT. Combined androgen deprivation therapy and radiation therapy resulted in a complete biochemical response.
引用
- Wondergem M, Srbljin S, van der Zant FM, et al. 18F-DCFPyL PET/CT in a Single Large Metastasis With Prostate-Specific Antigen Level of 856 ng/mL. Clin Nucl Med. 2019. PMID: 31274553. doi:10.1097/RLU.0000000000002690
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。